DK3774862T3 - Nye GLP-1-analoger - Google Patents

Nye GLP-1-analoger Download PDF

Info

Publication number
DK3774862T3
DK3774862T3 DK19724915.4T DK19724915T DK3774862T3 DK 3774862 T3 DK3774862 T3 DK 3774862T3 DK 19724915 T DK19724915 T DK 19724915T DK 3774862 T3 DK3774862 T3 DK 3774862T3
Authority
DK
Denmark
Prior art keywords
analogs
new glp
glp
new
Prior art date
Application number
DK19724915.4T
Other languages
English (en)
Inventor
Rajamannar Thennati
Nishith Chaturvedi
Vinod Sampatrao Burade
Pradeep Dinesh Shahi
Muthukumaran Natarajan
Ravishankara Madavati Nagaraja
Rishit Mansukhlal Zalawadia
Kunal Pandya
Brijeshkumar Patel
Dhiren Rameshchandra Joshi
Krunal Harishbhai Soni
Abhishek Tiwari
Vipulkumar Shankarbhai Patel
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Application granted granted Critical
Publication of DK3774862T3 publication Critical patent/DK3774862T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
DK19724915.4T 2018-04-05 2019-04-05 Nye GLP-1-analoger DK3774862T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201821013109 2018-04-05
IN201821040468 2018-10-26
IN201821040474 2018-10-26
PCT/IB2019/052835 WO2019193576A1 (en) 2018-04-05 2019-04-05 Novel glp-1 analogues

Publications (1)

Publication Number Publication Date
DK3774862T3 true DK3774862T3 (da) 2022-09-05

Family

ID=66589592

Family Applications (2)

Application Number Title Priority Date Filing Date
DK22177403.7T DK4122954T3 (da) 2018-04-05 2019-04-05 Novel GLP-1-analoger
DK19724915.4T DK3774862T3 (da) 2018-04-05 2019-04-05 Nye GLP-1-analoger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK22177403.7T DK4122954T3 (da) 2018-04-05 2019-04-05 Novel GLP-1-analoger

Country Status (30)

Country Link
US (6) US11447535B2 (da)
EP (3) EP4364751A3 (da)
JP (2) JP7250814B2 (da)
KR (1) KR20200141469A (da)
CN (2) CN112236444A (da)
AU (2) AU2019247936C1 (da)
BR (1) BR112020020419A2 (da)
CA (1) CA3095988A1 (da)
CL (1) CL2020002574A1 (da)
CO (1) CO2020012425A2 (da)
DK (2) DK4122954T3 (da)
EC (1) ECSP20070185A (da)
ES (1) ES2925678T3 (da)
FI (1) FI4122954T3 (da)
HR (1) HRP20221054T1 (da)
HU (1) HUE060135T2 (da)
IL (1) IL277483A (da)
JO (1) JOP20200251A1 (da)
LT (2) LT4122954T (da)
MX (1) MX2020010505A (da)
PE (1) PE20211417A1 (da)
PH (1) PH12020551591A1 (da)
PL (1) PL3774862T3 (da)
PT (1) PT3774862T (da)
RS (1) RS63523B1 (da)
SG (1) SG11202009467YA (da)
SI (1) SI3774862T1 (da)
UA (1) UA128210C2 (da)
WO (1) WO2019193576A1 (da)
ZA (1) ZA202306729B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4364751A3 (en) * 2018-04-05 2024-06-26 Sun Pharmaceutical Industries Limited Novel glp-1 analogues
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
TW202216746A (zh) * 2020-06-22 2022-05-01 印度商太陽製藥工業有限公司 長效型ｇｌｐ－１／ｇｉｐ雙重促效劑
PE20231309A1 (es) * 2020-10-17 2023-08-24 Sun Pharmaceutical Ind Ltd Agonistas duales glp-1/gip
CN114685646B (zh) * 2020-12-31 2023-04-07 厦门赛诺邦格生物科技股份有限公司 一种多肽侧链类似物的制备方法及其应用
CA3204051A1 (en) 2021-01-20 2022-07-28 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
CN115785249B (zh) * 2022-10-13 2023-07-21 江苏师范大学 一类glp-1类似物及其应用
CN117756914A (zh) * 2023-12-15 2024-03-26 瀚晖制药有限公司 依柯胰岛素的制备方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
PL192359B1 (pl) 1996-08-30 2006-10-31 Novo Nordisk As Pochodna GLP-1(7-37) lub analogu GLP-1(7-37), środek farmaceutyczny oraz zastosowanie pochodnej GLP-1(7-37) lub analogu GLP-1(7-37)
EP1062240B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S N-terminally modified glp-1 derivatives
WO1999043705A1 (en) 1998-02-27 1999-09-02 Novo Nordisk A/S N-terminally truncated glp-1 derivatives
EP1056775B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
ATE466027T1 (de) 1998-02-27 2010-05-15 Novo Nordisk As Abkömmlinge von glp-1 analogen
FR2777283B1 (fr) 1998-04-10 2000-11-24 Adir Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2000034331A2 (en) 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
EP1695983B1 (en) 2000-06-16 2009-03-04 Eli Lilly & Company Glucagon-like peptide-1 analogs
IL155812A0 (en) 2000-12-07 2003-12-23 Lilly Co Eli Glp-1 fusion proteins
WO2003058203A2 (en) 2002-01-08 2003-07-17 Eli Lilly And Company Extended glucagon-like peptide-1 analogs
US7291594B2 (en) 2002-10-11 2007-11-06 Sanwa Kagaku Kenkyusho Co., Ltd. GLP-1 derivative and preparation thereof absorbable via mucous membrane
WO2004078777A2 (en) 2003-03-04 2004-09-16 Biorexis Pharmaceutical Corporation Dipeptidyl-peptidase protected proteins
EP1633384B1 (en) 2003-05-15 2012-03-14 Trustees Of Tufts College Stable analogs of glp-1
TW200526254A (en) 2003-09-19 2005-08-16 Novo Nordisk As Novel GLP-1 derivatives
JP2007536214A (ja) 2003-12-16 2007-12-13 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Ｇｌｐ−１類似体
JP2008515856A (ja) 2004-10-07 2008-05-15 ノボ ノルディスク アクティーゼルスカブ 遅延性ｇｌｐ−１化合物
TWI362392B (en) * 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
US8603972B2 (en) 2005-03-18 2013-12-10 Novo Nordisk A/S Extended GLP-1 compounds
CA2607566A1 (en) 2005-05-06 2006-11-16 Bayer Pharmaceuticals Corporation Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
EP2497781A1 (en) 2005-09-08 2012-09-12 Trustees Of Tufts College Stabilized GLP-1 analogs
PL1767545T3 (pl) 2005-09-22 2010-04-30 Biocompatibles Uk Ltd Polipeptydy fuzyjne GLP-1 (glukagonopodobny peptyd-1) o zwiększonej odporności na peptydazy
US20100261637A1 (en) 2007-09-05 2010-10-14 Novo Nordisk A/S Peptides derivatized with a-b-c-d- and their therapeutical use
CA2702289A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Compounds exhibiting glucagon antagonist and glp-1 agonist activity
PL2513140T3 (pl) 2009-12-16 2016-04-29 Novo Nordisk As Podwójnie acylowane pochodne glp-1
CA2797431C (en) 2010-04-27 2016-06-21 Zhejiang Beta Pharma Inc. Glucagon-like peptide-1 analogue and use thereof
WO2012016419A1 (zh) 2010-08-06 2012-02-09 浙江贝达药业有限公司 Glp-1衍生物及其应用
US9708383B2 (en) 2010-11-09 2017-07-18 Novo Nordisk A/S Double-acylated GLP-1 derivatives
HUE031405T2 (en) 2011-04-12 2017-07-28 Novo Nordisk As Double-acylated GLP-1 derivatives
WO2012150503A2 (en) 2011-05-03 2012-11-08 Zealand Pharma A/S Glu-glp-1 dual agonist signaling-selective compounds
ES2626013T3 (es) 2011-09-06 2017-07-21 Novo Nordisk A/S Derivados de GLP-1
EP2578599A1 (en) 2011-10-07 2013-04-10 LanthioPep B.V. Cyclic analogs of GLP-1 and GLP-1 related peptides
CN104411322B (zh) 2012-05-08 2017-05-24 诺和诺德股份有限公司 双酰化glp‑1衍生物
EP2846823B1 (en) 2012-05-08 2019-12-04 Novo Nordisk A/S Double-acylated glp-1 derivatives
CN104583234A (zh) 2012-06-14 2015-04-29 赛诺菲 毒蜥外泌肽-4肽类似物
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
TWI674270B (zh) 2012-12-11 2019-10-11 英商梅迪繆思有限公司 用於治療肥胖之升糖素與glp-1共促效劑
BR112015014510A2 (pt) 2012-12-21 2017-11-21 Sanofi Sa agonistas de glp1/gip duais ou de glp1/gip/glucagon trigonais
BR112015030948A2 (pt) 2013-06-20 2017-09-19 Novo Nordisk As Derivados de glp-1 e usos dos mesmos
WO2014209886A1 (en) 2013-06-23 2014-12-31 Wisconsin Alumni Research Foundation Alpha/beta-polypeptide analogs of glucagon-like peptid-1
CA2916311A1 (en) 2013-07-04 2015-01-08 Novo Nordisk A/S Derivatives of glp-1 like peptides, and uses thereof
WO2015022400A1 (en) 2013-08-15 2015-02-19 Novo Nordisk A/S Glp-1 derivatives, and uses thereof
CN105745222A (zh) * 2013-10-17 2016-07-06 西兰制药公司 酰化胰高血糖素类似物
EP3080149A1 (en) 2013-12-13 2016-10-19 Sanofi Dual glp-1/glucagon receptor agonists
WO2015086731A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
KR20160098406A (ko) 2013-12-13 2016-08-18 메디뮨 리미티드 프로테아제 내성 펩티드
EP3226906B1 (en) 2014-11-27 2019-06-12 Novo Nordisk A/S Glp-1 derivatives and uses thereof
US10392428B2 (en) 2014-12-17 2019-08-27 Novo Nordisk A/S GLP-1 derivatives and uses thereof
TWI726889B (zh) 2015-06-10 2021-05-11 英商梅迪繆思有限公司 蛋白酶抗性之脂化肽
WO2017035432A1 (en) 2015-08-26 2017-03-02 Robert Doyle Coagonists of glucagon-like peptide 1 receptor and neuropeptide y2 receptor
EP3423481B1 (en) 2016-03-03 2020-10-07 Novo Nordisk A/S Glp-1 derivatives and uses thereof
KR20190017017A (ko) 2016-06-09 2019-02-19 메디뮨 리미티드 프로테아제-내성 모노-지질화된 펩타이드
JP7076442B2 (ja) 2016-11-07 2022-05-27 ノヴォ ノルディスク アー／エス Ｐｅｇ化合物のｄｃｈｂｓ活性エステル及びその使用
TW201833131A (zh) 2016-12-02 2018-09-16 法商賽諾菲公司 作為胜肽類ｇｌｐ１／升糖素／ｇｉｐ受體促效劑之新化合物
WO2018178796A1 (en) * 2017-03-27 2018-10-04 Sun Pharmaceutical Industries Limited Method for making kex1 protease sensitive polypeptides using yeast strain
ES2962666T3 (es) 2018-03-09 2024-03-20 Fresenius Kabi Ipsum S R L Síntesis quimioenzimática de liraglutida, semaglutida y GLP-1
EP4364751A3 (en) * 2018-04-05 2024-06-26 Sun Pharmaceutical Industries Limited Novel glp-1 analogues

Also Published As

Publication number Publication date
US11873328B2 (en) 2024-01-16
EP4122954A1 (en) 2023-01-25
AU2019247936B2 (en) 2023-03-02
EP3774862A1 (en) 2021-02-17
BR112020020419A2 (pt) 2021-01-19
AU2019247936A1 (en) 2020-10-15
EP3774862B1 (en) 2022-06-08
CA3095988A1 (en) 2019-10-10
US20220402992A1 (en) 2022-12-22
PL3774862T3 (pl) 2022-10-03
CL2020002574A1 (es) 2021-06-04
US20220402991A1 (en) 2022-12-22
JP2023078367A (ja) 2023-06-06
IL277483A (en) 2020-11-30
CO2020012425A2 (es) 2020-12-21
UA128210C2 (uk) 2024-05-08
PE20211417A1 (es) 2021-08-02
LT4122954T (lt) 2024-06-25
KR20200141469A (ko) 2020-12-18
PH12020551591A1 (en) 2021-08-16
CN117964735A (zh) 2024-05-03
DK4122954T3 (da) 2024-06-10
US11485766B2 (en) 2022-11-01
ECSP20070185A (es) 2021-01-29
US20240199718A1 (en) 2024-06-20
US20200362007A1 (en) 2020-11-19
US11866477B2 (en) 2024-01-09
WO2019193576A1 (en) 2019-10-10
SI3774862T1 (sl) 2022-10-28
JOP20200251A1 (ar) 2020-10-04
FI4122954T3 (fi) 2024-06-18
US20210206823A1 (en) 2021-07-08
LT3774862T (lt) 2022-09-12
HRP20221054T1 (hr) 2022-11-11
ZA202306729B (en) 2024-03-27
US11447535B2 (en) 2022-09-20
MX2020010505A (es) 2021-01-15
AU2023203430A1 (en) 2023-06-29
RS63523B1 (sr) 2022-09-30
EP4364751A2 (en) 2024-05-08
JP7250814B2 (ja) 2023-04-03
SG11202009467YA (en) 2020-10-29
JP2021520346A (ja) 2021-08-19
HUE060135T2 (hu) 2023-02-28
US20190309040A1 (en) 2019-10-10
US11242373B2 (en) 2022-02-08
EP4122954B1 (en) 2024-04-03
ES2925678T3 (es) 2022-10-19
AU2019247936C1 (en) 2023-06-15
CN112236444A (zh) 2021-01-15
PT3774862T (pt) 2022-09-05
EP4364751A3 (en) 2024-06-26

Similar Documents

Publication Publication Date Title
DK3774862T3 (da) Nye GLP-1-analoger
DK3883936T3 (da) Nye heterocykliske forbindelser
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
MA52090A (fr) Polythérapie
DK3870578T3 (da) Terapeutiske forbindelser
DK3445742T3 (da) Krystallin tapentadolphosphat
DK3412667T3 (da) Cokrystal
DK3809821T3 (da) Polytunnelstruktur
DK3620208T3 (da) Kanyle
CA185480S (fr) Auto-injector
DK3752258T3 (da) Trampolin
UA38819S (uk) Нерухомий зрошувач
UA40472S (uk) Наголовний убор
UA40473S (uk) Наголовний убор
IT201800002458A1 (it) ALTERNAUTO DINAMORUN by Mb
DK3587968T3 (da) Fluidsystem
ES1214464Y (es) Estructura polivalente
MA49925A (fr) Claie
DE112019000442A5 (de) Ringtilgereinrichtung
NO20181678A1 (no) Rissanviser
JP1628555S (ja) たい焼
JP1628556S (ja) たい焼
ES1218724Y (es) Terrario
UY4630S (es) Piscina
ES1224156Y (es) Ecobolsera